Keyphrases
Confidence Interval
100%
Type 1 Diabetes Mellitus (T1DM)
93%
Denmark
83%
COVID-19
82%
Type I Diabetes
76%
Respiratory Syncytial Virus
64%
Heart Failure
61%
National Cohort Study
56%
Type 2 Diabetes Mellitus (T2DM)
51%
Atrial Fibrillation
50%
Hospitalization
49%
All-cause Mortality
48%
Out-of-hospital Cardiac Arrest
46%
Hazard Ratio
43%
Type 2 Diabetic Patients
39%
Risk Factors
35%
Randomized Controlled Trial
34%
Odds Ratio
32%
Comorbidity
32%
Nationwide Registry
30%
Incidence Rate
28%
Physical Activity
27%
Hypoglycemia
25%
Europe
24%
Cardiovascular Disease
23%
Myocardial Infarction
23%
European Countries
23%
Diabetes
23%
Severe Hypoglycemia
22%
Hospital Admission
22%
Liraglutide
21%
Continuous Glucose Monitoring
21%
High Risk
21%
Respiratory Syncytial Virus Infection
20%
AIMS™
19%
Older Adults
19%
Exercise Training
19%
Heart Failure Patients
19%
Quality of Life
19%
Nationwide Registers
18%
Patients with Heart Failure
18%
Patients with Diabetes
18%
Meta-analysis
18%
Cardiovascular Risk
18%
Physical Activity Level
18%
Pregnant Women
17%
Chronic Kidney Disease
17%
Ischemic Stroke
16%
Healthcare Workers
16%
Cardiovascular Mortality
16%
Systematic Meta-analysis
16%
Hemoglobin A1c (HbA1c)
16%
COVID-19 Pandemic
15%
Risk Ratio
15%
Mortality Risk
14%
Chronic Obstructive Pulmonary Disease
14%
Health-related Quality of Life
13%
Acute Kidney Injury
13%
Register Study
13%
Beta-blockers
13%
Obstructive Sleep Apnea
13%
Venous Thromboembolism
12%
Absolute Risk
12%
Non-polio Enteroviruses
12%
Peripheral Arterial Disease
12%
Cardiovascular Events
12%
Insulin Therapy
12%
Hospitalized Patients
12%
Ischemic Heart Disease
12%
Without Diabetes
12%
Registry-based
12%
Placebo
12%
Cardiovascular Outcomes
11%
Lockdown
11%
Danish Registry
11%
Emergency Medical Services
11%
Carotid Intima-media Thickness (cIMT)
11%
Infective Endocarditis
11%
Supervised Exercise
11%
Disease Severity
11%
Insulin Analogues
11%
Copenhagen
11%
Blood Pressure
11%
Insulin Degludec
10%
Registry Study
10%
30-day Survival
10%
Observational Cohort Study
10%
Adverse Events
10%
Secondary Prevention
10%
SARS-CoV-2 Infection
10%
Nursing Home Admission
10%
Age Groups
10%
Non-associated
10%
Transient Ischemic Attack
10%
Cumulative Incidence
10%
Glucagon-like
9%
Disease Burden
9%
Insulin
9%
Seroprevalence
9%
Temporal Trends
9%
Medicine and Dentistry
Cohort Analysis
74%
COVID-19
65%
Heart Failure
58%
Diabetes
46%
Infection
44%
Severe Acute Respiratory Syndrome Coronavirus 2
42%
Atrial Fibrillation
40%
Cardiovascular System
37%
Out of Hospital Cardiac Arrest
35%
Randomized Controlled Trial
34%
Maturity Onset Diabetes of the Young
33%
Human Respiratory Syncytial Virus
32%
Cardiovascular Disease
31%
Apoplexy
27%
Hazard Ratio
27%
Physical Activity
25%
Patient with Type 2 Diabetes
25%
Insulin Dependent Diabetes Mellitus
24%
All Cause Mortality
23%
Disease
21%
Odds Ratio
21%
Intensive Care Unit
19%
Liraglutide
17%
Patient with Type 1 Diabetes
16%
Quality of Life
16%
Prevalence
16%
Placebo
15%
Acute Kidney Injury
15%
Hemoglobin A1c
14%
Myocardial Infarction
14%
Hypoglycemia
14%
Proportional Hazards Model
14%
Systematic Review
14%
Triage
13%
Respiratory Syncytial Virus Infection
13%
Respiratory Tract Infection
13%
Meta-Analysis
13%
Symptom
13%
Acute Coronary Syndrome
13%
Diabetes Mellitus
13%
Adverse Event
12%
Chronic Obstructive Pulmonary Disease
11%
Brain Ischemia
11%
Venous Thromboembolism
11%
Intima-Media Thickness
10%
Heart Arrest
10%
Nursing Home
10%
Ischemic Heart Disease
10%
Antithrombotic
9%
Mortality Rate
9%
Exercise
9%
Secondary Prevention
9%
Cumulative Incidence
9%
Arteriosclerosis Obliterans
9%
Health Care
9%
Infective Endocarditis
9%
Body Mass Index
8%
Omicron Coronavirus Variant
8%
Blood Pressure
8%
Coronary Angiography
8%
Diabetic Nephropathy
8%
End Stage Renal Disease
8%
Population
8%
Resuscitation
8%
Enterovirus
7%
Defibrillator
7%
Pregnancy
7%
Glucagon-Like Peptide-1 Agonist
7%
Insulin Derivative
7%
Poliomyelitis Virus
7%
Defibrillation
7%
Glycon
7%
Cross Sectional Study
7%
Biological Marker
7%
Transient Ischemic Attack
7%
Cardiovascular Risk
7%
Patient Characteristics
6%
Logistic Regression Analysis
6%
Retrospective Cohort Study
6%
Aortic Valve Replacement
6%
Obstructive Sleep Apnea
6%
Asthma
6%
Public Health
6%
Colonoscopy
6%
Implantable Automatic Defibrillator
6%
Patient with Diabetes
6%
Insulin Treatment
6%
Thromboembolism
6%
Cardiac Troponin
6%
Troponin T
6%
Cardiogenic Shock
6%
Ulcer
6%
Diabetic Foot Ulcer
6%
Chronic Kidney Disease
6%
Randomized Clinical Trial
6%
Glycemic Control
6%
Intensive Care
6%
Drug Therapy
6%
Case-Control Study
6%
Glycemic
6%